Related Experiment Video
Updated: Nov 30, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics
Yoric Gagnebin1,2, David A Jaques3, Serge Rudaz1,2,4
1School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Insights
Metabolomics reveals distinct metabolic patterns between chronic kidney disease (CKD) and hemodialysis (HD) patients. These differences in metabolite profiles could explain the higher morbidity and mortality observed in patients undergoing HD.
Area of Science:
- Nephrology
- Metabolomics
- Biochemistry
Background:
- Chronic kidney disease (CKD) involves uremic solute retention.
- Patients requiring hemodialysis (HD) exhibit higher morbidity and mortality than non-dialysis CKD patients.
Purpose of the Study:
- To characterize and compare metabolic patterns in non-dialysis CKD patients and HD patients using metabolomics.
- To identify specific metabolite differences that may explain clinical disparities.
Main Methods:
- Screened prevalent non-HD CKD (KDIGO stage 3b-4) and stage 5 HD outpatients.
- Utilized liquid chromatography-mass spectrometry to identify 278 metabolites.
- Applied unsupervised and supervised data analyses to characterize metabolic profiles.
Main Results:
- Metabolomics analysis revealed distinct clustering of CKD, pre-dialysis (preHD), and post-dialysis (postHD) patient groups.
- Significant qualitative and quantitative differences in metabolite profiles were observed between CKD, preHD, and postHD states.
- A metabolomics framework successfully discriminated between CKD stages and highlighted the effects of HD.
Conclusions:
- Metabolic patterns significantly differ between CKD and HD patients.
- These identified metabolic differences may elucidate the increased clinical risks associated with hemodialysis.
- Metabolomics provides a framework for understanding disease progression and treatment effects in kidney disease.
Abstract:
Chronic kidney disease (CKD) is characterized by retention of uremic solutes. Compared to patients with non-dialysis dependent CKD, those requiring haemodialysis (HD) have increased morbidity and mortality. We wished to characterise metabolic patterns in CKD compared to HD patients using metabolomics. Prevalent non-HD CKD KDIGO stage 3b-4 and stage 5 HD outpatients were screened at a single tertiary hospital. Various liquid chromatography approaches hyphenated with mass spectrometry were used to identify 278 metabolites. Unsupervised and supervised data analyses were conducted to characterize metabolic patterns. 69 patients were included in the CKD group and 35 in the HD group. Unsupervised data analysis showed clear clustering of CKD, pre-dialysis (preHD) and post-dialysis (postHD) patients. Supervised data analysis revealed qualitative as well as quantitative differences in individual metabolites profiles between CKD, preHD and postHD states. An original metabolomics framework could discriminate between CKD stages and highlight HD effect based on 278 identified metabolites. Significant differences in metabolic patterns between CKD and HD patients were found overall as well as for specific metabolites. Those findings could explain clinical discrepancies between patients requiring HD and those with earlier stage of CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management

